Drug intelligence / Profile preview

LYCOBEN

Development stage: Unknown
Lead developer: Ben Pharmaceuticals
Modality: Small Molecules
Administration: Oral

Overview

LYCOBEN is an antioxidant dietary supplement developed by Ben Pharmaceuticals, typically formulated as softgel capsules. It contains a combination of lycopene, a potent carotenoid antioxidant, along with vitamins (A, C, and E) and minerals (Zinc and Selenium). The product is designed to combat oxidative stress by scavenging reactive oxygen species and supporting the body's endogenous antioxidant defense systems. It is commonly used as a nutritional adjunct to support cardiovascular health, immune function, and reproductive health, particularly in conditions associated with high oxidative damage such as male infertility.

Brand names: LYCOBEN
Other names: Lycopene with Multivitamins and Minerals

Targets

RAR (Retinoic acid receptor)Misfolded SOD1GPX4 (Glutathione peroxidase 4)

Beyond the preview

Go deeper on LYCOBEN.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on LYCOBEN.

Explore the full profile